Jul 23 |
HHS gives thumbs down to bluebird’s fertility support programme
|
Jul 23 |
Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?
|
Jul 22 |
Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today
|
Jul 22 |
3 Gene Editing Stocks Shaping the Future of Medicine
|
Jul 21 |
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street
|
Jul 20 |
3 Monster Stocks in the Making to Buy Right Now
|
Jul 19 |
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Jul 17 |
3 Gene Editing Stocks That Could Grow Your Wealth
|
Jul 16 |
Vertex taps Orum to hunt for better ‘preconditioning’ drugs
|
Jul 16 |
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
|